HLS Therapeutics Inc.
HLS Therapeutics Inc. (HLTRF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HLTRF · as of Jun 9, 2026
Key Statistics
Explore HLS Therapeutics Inc. Data
hltrf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
hltrf competitorsHLTRF
AAWH
CBWTF
HOFBF
JUSHF
LDXHFStock Performance
Full HistoryAbout HLS Therapeutics Inc.
HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiova…
what is hls therapeutics inc. · hltrf stock overview · hls therapeutics inc. company profile · who is hls therapeutics inc. ceo · hltrf OTC · hls therapeutics inc. headquarters · hls therapeutics inc. business segments
About Stock Overview & Key Data
HLS Therapeutics Inc. (HLTRF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 27, 2010. As of the latest trading session, HLTRF stock price is $3.15, with a market capitalization of $98.5M. The stock has returned -13.93% over the past 12 months and -8.16% year-to-date.
According to 1 Wall Street analysts, the consensus rating for HLS Therapeutics Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, HLS Therapeutics Inc. reported revenue of $56.5M and net income of -$12.6M. For detailed data — including HLS Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HLS Therapeutics Inc. (HLTRF) stock price is $3.15. The stock is traded on OTC under the ticker symbol HLTRF. The 52-week range is $3.00 – $4.02.